News Zhejiang Int'l Group Co.,Ltd.

Equities

000411

CNE0000008D9

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
10.26 ^CNY	+0.49%		-0.39%	-8.47%

Apr. 19	Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Cash Dividend on A Shares for 2022, Payable on 08 June 2023	23-06-01	CI
Zhejiang Int'l Group Co.,Ltd. Approves Cash Dividend for 2022	23-05-22	CI
Zhejiang Int'l Group Co.,Ltd. Announces Profit Distribution Proposal for 2022	23-05-04	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire 51% stake in Hangzhou Baishan Medical Equipment Co., Ltd. from Shanghai Youjiang Enterprise Development Center (Limited Partnership), Shanghai Tuyu Enterprise Development Center (Limited Partnership), Yun Naiyi and Huang Haihua for CNY 100 million.	23-04-11	CI
Zhejiang International to Buy Out Local Pharma Firm in 1.2 Billion Yuan Share Transfer Deal	23-04-11	MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
Zhejiang Int'l Group Co.,Ltd. announced that it has received CNY 399.999996 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd.	23-03-15	CI
Zhejiang International Secures Nod to Sell 400 Million Yuan of Shares	23-03-02	MT
Zhejiang Int'l Group Co.,Ltd. completed the acquisition of remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd.	23-02-27	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Zhejiang Int'l Group Co.,Ltd. announces decision of Shareholder/Board on the transaction	22-10-24	CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 400 million in funding	22-10-24	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022	22-06-13	CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd for CNY 2.3 billion.	22-05-25	CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 449.99955 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd.	22-05-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Int'l Group Co.,Ltd.

Equities

000411

CNE0000008D9

Summary

Filters